Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| macrophage | 19 studies | 27% ± 10% | |
| myeloid cell | 9 studies | 26% ± 8% | |
| microglial cell | 8 studies | 22% ± 5% | |
| classical monocyte | 7 studies | 24% ± 8% | |
| monocyte | 5 studies | 26% ± 4% | |
| alveolar macrophage | 5 studies | 28% ± 11% | |
| non-classical monocyte | 4 studies | 27% ± 9% | |
| endothelial cell | 4 studies | 21% ± 5% | |
| epithelial cell | 4 studies | 24% ± 7% | |
| conventional dendritic cell | 3 studies | 22% ± 8% | |
| hematopoietic precursor cell | 3 studies | 20% ± 6% | |
| tissue-resident macrophage | 3 studies | 25% ± 2% | |
| fibroblast | 3 studies | 20% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 6281.23 | 1445 / 1445 | 100% | 102.12 | 183 / 183 |
| stomach | 100% | 4128.96 | 359 / 359 | 100% | 92.00 | 286 / 286 |
| uterus | 100% | 7237.94 | 170 / 170 | 100% | 123.40 | 459 / 459 |
| skin | 100% | 9309.21 | 1808 / 1809 | 100% | 145.16 | 472 / 472 |
| lung | 100% | 9835.20 | 578 / 578 | 100% | 112.65 | 1153 / 1155 |
| breast | 100% | 7679.17 | 459 / 459 | 100% | 103.47 | 1116 / 1118 |
| ovary | 100% | 6051.24 | 180 / 180 | 100% | 82.42 | 429 / 430 |
| intestine | 100% | 7067.48 | 966 / 966 | 99% | 103.64 | 524 / 527 |
| bladder | 100% | 7840.05 | 21 / 21 | 99% | 109.98 | 500 / 504 |
| prostate | 100% | 5216.70 | 244 / 245 | 99% | 45.69 | 496 / 502 |
| liver | 100% | 3079.14 | 226 / 226 | 97% | 50.91 | 393 / 406 |
| kidney | 99% | 3939.25 | 88 / 89 | 97% | 81.56 | 873 / 901 |
| pancreas | 95% | 2566.18 | 312 / 328 | 98% | 107.58 | 175 / 178 |
| thymus | 100% | 4295.33 | 652 / 653 | 92% | 33.09 | 559 / 605 |
| adrenal gland | 100% | 4203.30 | 258 / 258 | 89% | 41.61 | 205 / 230 |
| brain | 86% | 2353.66 | 2272 / 2642 | 98% | 53.70 | 691 / 705 |
| adipose | 100% | 9898.61 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 89.35 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 95.06 | 29 / 29 |
| spleen | 100% | 13397.67 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 128.87 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 36.27 | 1 / 1 |
| blood vessel | 100% | 7480.39 | 1333 / 1335 | 0% | 0 | 0 / 0 |
| heart | 99% | 3944.20 | 854 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 99% | 8531.50 | 920 / 929 | 0% | 0 | 0 / 0 |
| muscle | 88% | 2058.28 | 707 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0030199 | Biological process | collagen fibril organization |
| GO_1904028 | Biological process | positive regulation of collagen fibril organization |
| GO_0005788 | Cellular component | endoplasmic reticulum lumen |
| GO_0016020 | Cellular component | membrane |
| GO_0050211 | Molecular function | procollagen galactosyltransferase activity |
| Gene name | COLGALT1 |
| Protein name | Collagen beta(1-O)galactosyltransferase 1 procollagen galactosyltransferase (EC 2.4.1.50) Procollagen galactosyltransferase 1 (EC 2.4.1.50) (Collagen beta(1-O)galactosyltransferase 1) (ColGalT 1) (Glycosyltransferase 25 family member 1) (Hydroxylysine galactosyltransferase 1) |
| Synonyms | PSEC0241 GLT25D1 |
| Description | FUNCTION: Beta-galactosyltransferase that transfers beta-galactose to hydroxylysine residues of type I collagen . By acting on collagen glycosylation, facilitates the formation of collagen triple helix . Also involved in the biosynthesis of collagen type IV . . |
| Accessions | ENST00000252599.9 A0A8I5QKL8 ENST00000597147.2 A0A8I5QL08 ENST00000690841.1 ENST00000690947.1 ENST00000690106.1 Q8NBJ5 M0QX72 |